Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,046 public trials 269 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

NCT07006506

Conditions
Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +6 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) Commack, New York, United States
View Trial Details
Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

NCT04068597

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +27 more
Locations
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Community Health Network Indianapolis, Indiana, United States
  • The Center for Cancer and Blood Disorders (CCBD) Bethesda, Maryland, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
View all 39 locations
View Trial Details
Recruiting

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

NCT06579469

Conditions
B-ALL, Hematologic Diseases, Hematologic Malignancy, +5 more
Locations
  • Childrens Hospital of Colorado Aurora, Colorado, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
  • Primary Children's Hospital Salt Lake City, Utah, United States
View Trial Details
Recruiting

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

NCT02074839

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-AZ Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California-Los Angeles Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions